Navigation Links
Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
Date:4/29/2013

Boston, MA (PRWEB) April 29, 2013

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that the latest Genedata software solutions will be featured at the Ninth Annual PEGS. Genedata Biologics™, an end-to-end solution for biologics R&D, will be showcased in the PEGS Phage and Yeast Display of Antibodies and Recombinant Proteins Session. The presentation will detail screening automation use cases from phage, yeast, and mRNA displays, as well as hybridomas and B-cells. Advanced workflow support for affinity maturation, the design and evaluation of engineered molecules, and subsequent automated expression, purification, and characterization of novel biologics candidates using Genedata Biologics will be presented. Genedata Biologics and Genedata Expressionist® for Mass Spectrometry will also be featured in poster sessions at PEGS, the foremost protein engineering summit (Seaport World Trade Center; April 29 – May 3).

Genedata Biologics and Genedata Expressionist for Biologics R&D
Genedata provides dedicated data management solutions tailored to address specific requirements in biologics R&D. Simplifying and streamlining laborious and manual lab processes such as cloning, the Genedata Biologics platform increases efficiency and throughput while reducing data handling errors to improve results quality. Automating and standardizing protein characterization processes, Genedata Expressionist for Mass Spectrometry , for example, identifies and quantifies post-translational modifications (PTMs) of biotherapeutics to assess developability.

PEGS presentation and poster sessions will examine how Genedata enables more flexible and ultra high-throughput workflows, and how classic process bottlenecks can be removed. Concrete use cases will include:

  • High-throughput engineering, cloning and expression of multi-specific next-generation antibodies
  • Expression system optimization and bioprocess development
  • Automation of mass spectrometry data analysis for biotherapeutics

“Through our close collaboration over the last five years with industry leaders combined with significant investments in resources, Genedata has been able to solve major data integration and analysis problems in biotherapeutics R&D,” noted Dr. Othmar Pfannes, CEO of Genedata. “Our investments have created a unique software solution for R&D organizations in need of scientific data integration and analysis. And, we are fully committed to continuing these investments and expanding the solution so that it becomes the platform of choice for biopharmaceutical R&D as well as biotherapeutics and biosimilars manufacturing.”

Editorial Note: On April 29 at 12:10pm EST, Genedata Biologics will be featured in the PEGS Phage and Yeast Display of Antibodies and Recombinant Proteins Session -- “Automated High-throughput Antibody Discovery and Optimization” -- by Dr. Christopher Smith. To schedule a briefing contact, jackie.thrasivoulos genedata.com.

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. http://www.genedata.com.

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Read the full story at http://www.prweb.com/releases/PEGS_Protein_Engineering/Bispecific_ADCs_Antibody/prweb10670569.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genedata Screener to Present at 10th Annual Ion Channel Retreat
2. Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
3. Genedata Screener for HCS Advances Phenotypic Screening
4. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
5. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
6. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
7. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
8. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
9. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
10. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
11. CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... , April 27, 2017  Kinexum, a distinguished resource ... today announces the appointment of Thomas C. Seoh ... ("Zan") Fleming, M.D., Kinexum founder, who becomes Executive Chairman ... to Kinexum clients. Thomas Seoh ... the Kinexum mission and lead the firm,s remarkable team ...
(Date:4/26/2017)... ... April 26, 2017 , ... Baltimore ... Bioflash MailGuardtm mail security screening solution at the National Postal Forum 2017 in ... provides a fast, highly accurate, easy to use and low cost threat detection ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... supplier of Common Lisp (CL) development tools, and market leader for Semantic ... key performance enhancements now available within the most effective system for developing and ...
(Date:4/25/2017)... ... , ... Leaders of Quorum Review IRB and Kinetiq , ... this week’s Association of Clinical Research Professionals (ACRP) 2017 Meeting & Expo ... "We are excited to present subject matter expertise on topics that impact the global ...
Breaking Biology Technology:
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification ... Used combined in one project, multi-biometric solutions provide a ... ...
(Date:3/9/2017)... FRANCISCO and MOUNTAIN VIEW, Calif. ... , "Eating Well Made Simple," and 23andMe , ... help guide better food choices.  Zipongo can now provide ... their food preferences, health goals and biometrics, but also ... certain food choices. Zipongo,s personalized food decision ...
(Date:3/6/2017)... , March 6, 2017 ... sales technology, today announced Predictive Sales Coach TM ... infusing actionable sales intelligence into Salesforce. This unique ... enable their sales organizations with deep knowledge of ... allow for intelligent engagement. Predictive Sales Coach extends ...
Breaking Biology News(10 mins):